Jump to content

Talk:Bisphenol A diglycidyl ether

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
[edit]

Hello fellow Wikipedians,

I have just modified 2 external links on Bisphenol A diglycidyl ether. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at {{Sourcecheck}}).

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

  • If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
  • If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 08:28, 3 November 2016 (UTC)[reply]

Health concerns

[edit]

Why are the health concerns from this chemical's use as a food can lining so sketchy? Shouldn't its safety have been tested prior to its approval for this use? Do chemicals from the can lining ever migrate into the contents of food cans? 173.88.246.138 (talk) 17:02, 5 March 2021 (UTC)[reply]

BPADGE

[edit]

This product is not a solid at the molecular weight stated. It is liquid. I will leave for a few days then I am going to heavily edit if that is OK with everyone? GRALISTAIR (talk) 15:11, 11 January 2023 (UTC)[reply]

Reference[1]

CAS would agree with that (ref). Low level hydrolysis would contaminate it with Bis-HPPP, mpt 89-90°C, which might explain the difference (assuming it's not an error) --Project Osprey (talk) 16:05, 11 January 2023 (UTC)[reply]

What I am trying to do is avoid original research. I could cite my own Master of Science Thesis but that is not appropriate I feel. My company buys railcars of Bisphenol A DiGlycidyl Ether and can assure everyone it is a liquid. We bought a road tanker a day at my previous company. It can be (and is) advanced up with further bisphenol A and an advancement catalyst to higher molecular weight epoxies which are indeed solid. There are multiple suppliers, and I could upload all their technical data sheets but probably over the top and too commercial. There are plenty of peer reviewed journal papers on the subject. I will try and cite those that I have NOT peer reviewed and someone else has. GRALISTAIR (talk) 19:27, 11 January 2023 (UTC)[reply]

Now done. I was not patient! GRALISTAIR (talk) 20:07, 11 January 2023 (UTC)[reply]

I wouldn't worry too much. If your were posting links to your employer that would be COI, citing papers that you're been a reviewer (but not an author) for is fine. It's rare for a page like this to be edited by an expert user with real world knowledge. I would encourage you to be bold. --Project Osprey (talk) 00:26, 12 January 2023 (UTC)[reply]

References

  1. ^ PubChem. "Bisphenol A diglycidyl ether". pubchem.ncbi.nlm.nih.gov. Retrieved 2023-01-11.

Biological activity

[edit]

In the section 'N-Terminal domain antagonists' under Antiandrogen#Androgen_receptor_antagonists, I read that:

Examples of AR NTD antagonists include bisphenol A diglycidyl ether (BADGE) [...] [1][2]

That information was introduced by revision [1] in December 2016, and it seems surprising to see no mention of the same information on this page. Is there someone with a modicum of relevant expertise that could check whether it should be included? Hv (talk) 18:29, 19 February 2024 (UTC) Hv (talk) 18:29, 19 February 2024 (UTC)[reply]

References

  1. ^ Imamura Y, Sadar MD (August 2016). "Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic". International Journal of Urology. 23 (8): 654–665. doi:10.1111/iju.13137. PMC 6680212. PMID 27302572.
  2. ^ Martinez-Ariza G, Hulme C (2015). "Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer". Pharmaceutical Patent Analyst. 4 (5): 387–402. doi:10.4155/ppa.15.20. PMID 26389532.